What Is a Management Fee Waiver in Private Equity?

A management fee waiver is an election a private equity general partner makes to forgo its annual management fee — typically 2% of committed capital — in exchange for an increased profits interest in the fund. The strategy converts what would be ordinary income, taxed at rates up to 37%, into a capital-gains-eligible carry allocation. The IRS has scrutinized these arrangements since at least 2015, when Treasury published proposed regulations REG-115452-14 (80 FR 43652) establishing that any waiver lacking significant entrepreneurial risk will be treated as a disguised payment for services and taxed as ordinary income anyway.

The Basic Mechanics: Fee, Waiver, and Profits Interest

Every private equity fund charges its limited partners a management fee. The standard rate is 2% per year on committed capital during the investment period, then steps down to 1% to 1.5% on invested capital after deployment ends. That fee funds the GP's operations: salaries, legal costs, deal sourcing, and overhead.

A management fee waiver works as follows. Before the start of a fee period, the GP elects, in writing, not to receive its cash fee. The fund treats the waived amount as a deemed capital contribution from the GP, and the GP receives an equivalent profits interest in future fund income and gains. The GP does not put up new cash. The fund books a reduction in the management fee expense, and the GP's stake in future profits grows by a corresponding amount.

The economic difference is significant. A cash management fee is ordinary income to the GP's management company, taxed at up to 37% federally. A profits interest tied to future fund gains produces capital income, taxed at 20% plus 3.8% net investment income tax for most high earners. On a $400M fund with a 2% fee, the GP waives $8M per year. Converting that to capital-gains treatment saves roughly $1.4M annually in federal tax, assuming the structure qualifies under IRS standards.

The Tax Foundation: Rev. Proc. 93-27 and Its Limits

GPs have long relied on IRS Revenue Procedure 93-27 to support fee waiver arrangements. That procedure establishes that a profits interest received by a service provider for services rendered to a partnership is not a taxable event at grant. Under that logic, a GP waiving a fee and receiving a profits interest owes no immediate tax, and future allocations from that interest produce capital gain.

The 2015 proposed regulations challenged this reasoning directly. Treasury stated in the preamble to REG-115452-14 that Rev. Proc. 93-27 does not apply to fee waiver arrangements because the GP is not receiving a profits interest as a new service contributor. It is converting an existing, known fee obligation into preferred tax treatment. As law firm Proskauer Rose explained in its July 2015 client alert, the government's position is that the core principles in those proposed rules "apply under current law," even though final regulations have never been published. The IRS reserves the right to challenge fee waiver structures under current statute without waiting for finalization.

That point matters more than many GPs acknowledge. The Tax Law Center at NYU School of Law noted in 2025 that the proposed regulations "were never finalized" and recommended Treasury republish or finalize them to "curb the ongoing improper use of fee waiver arrangements." The legal uncertainty has allowed the practice to continue in varied forms, but the IRS's silence on finalization is not the same as approval of any particular structure.

The Significant Entrepreneurial Risk Test: What the IRS Is Looking For

The proposed regulations identify six factors for evaluating whether a fee waiver produces a legitimate profits interest or a disguised ordinary-income fee. One factor carries decisive weight: whether the arrangement is subject to "significant entrepreneurial risk." An arrangement that fails this test is treated as a disguised payment for services regardless of what the other five factors show.

The IRS defines significant entrepreneurial risk by asking whether the GP's profits allocation depends on genuine fund performance. Congress drew a clear line: partners extract profits based on business success, while service providers receive payments independent of that risk. A fee waiver that mimics the latter (where the GP is almost certain to receive an allocation of a predetermined size) is, in substance, a fee, not a capital allocation.

The proposed regulations list five specific circumstances that create a presumption of insufficient risk. If any of these apply, the arrangement is presumed to be a disguised fee unless the GP rebuts that presumption with clear and convincing evidence. Those five red-flag patterns are:

• Capped allocations, where the cap is reasonably expected to apply in most years
• Allocations for a fixed period during which the GP's income share is reasonably certain
• Allocations of gross income rather than net income, so the GP gets paid before the fund absorbs losses
• Allocations that are predominantly fixed in amount, reasonably determinable, or structured so that sufficient net profits are "highly likely" to be available
• Waivers that are non-binding, or where the GP fails to provide timely written notice to the fund and its partners before the fee period begins

That fifth point has direct implications for LPs. A waiver that is not binding and irrevocable before the fee period starts fails the test on procedural grounds alone. If the GP did not send advance written notice of the waiver to the fund and its partners, that fact is itself a problem under the proposed IRS framework.

By contrast, a waiver passes the significant entrepreneurial risk test when the profits interest tracks net income and gains across the full fund life, subject to a clawback if cumulative allocations exceed the fund's actual net profit, and where the ultimate outcome is neither reasonably determinable nor highly likely at the time of waiver. Venable LLP's analysis of the proposed regulations noted that if "a waiver is executed in advance and cannot be revoked and if the future profits allocation is neither 'highly likely' to be available nor 'reasonably determinable' at the time of the waiver, the proposed rules would not re-characterize a profits allocation related to a fee waiver as ordinary income."

Three Reasons Fee Waivers Matter to You as an LP

Fee waivers do not appear on your capital account statement. They do not reduce your quarterly distributions. On a surface reading, they look like an internal GP tax matter. That reading is incomplete, for three reasons.

First, the GP's tax incentives shape its behavior. A GP with a well-structured fee waiver has an even stronger economic stake in fund performance than a GP collecting flat cash fees. The waived fee converts into a carry-like profits interest, so the GP's economics depend directly on the portfolio generating net gains. That additional alignment can be a positive signal about GP motivation and skin-in-the-game commitments.

Second, a poorly structured waiver creates IRS exposure the fund itself may need to manage. If the IRS recharacterizes waived fees as ordinary income after the fact, the fund faces amended K-1s, possible Section 409A deferred compensation penalties, and legal costs. Those costs flow through fund expenses and can reduce your net returns. This is not a theoretical risk. It becomes a real cash drag if the fund is audited and loses the argument.

Third, the Institutional Limited Partners Association (ILPA) Model Limited Partnership Agreement explicitly addresses management fee waivers that convert fee income into LP interests. ILPA labels these arrangements "bad dilution" and recommends that LPAs prohibit them outright. When reviewing a fund's LPA, check whether the agreement permits the GP to take profits-interest allocations in lieu of fees, and whether LPs receive advance written notice of any such election. The ILPA model provides a clause-by-clause reference that any serious LP should use as a due-diligence baseline.

What to Ask Your GP Before You Commit Capital

I read fee waiver disclosures as a two-part test: structure and documentation. A waiver that passes both is a legitimate tax-planning tool. One that fails either is worth escalating before you sign a subscription agreement.

On structure, ask the GP to explain exactly what profits interest they receive in exchange for the waiver. That interest should track fund-level net income and gains across the full fund life, not gross income or returns from specific transactions. There should be a genuine clawback obligation tied to the fund's cumulative net profit over its life. The allocation must not be capped at a level the fund is nearly certain to reach given existing portfolio performance.

On documentation, ask when the waiver notice goes out and who receives it. The waiver must be binding and irrevocable before the relevant fee period starts, with written notice to the fund and to LPs. Informal or retroactive waivers fail the IRS test regardless of their economic substance.

Additional questions worth raising during diligence:

• Does the LPA disclose that fee waivers may occur, and does it require LP notice before each waiver period?
• Has outside fund counsel issued a tax opinion on the waiver arrangement and its compliance with the Section 707(a)(2)(A) framework?
• Is the GP's profits interest subject to the same capital account mechanics and clawback provisions as the carried interest?
• Has the fund ever been audited on this specific issue, and what was the outcome?

Legitimate Tax Planning vs. a Structural Red Flag

Fee waivers serve a real purpose when structured correctly. A GP that waives fees before the period begins, accepts genuine performance risk on the resulting profits interest, documents everything in writing, and discloses the arrangement to LPs is doing what profits interest law contemplates: creating alignment between GP economics and fund returns. I have no objection to that structure when the documentation is clean and the risk is real.

The red flag is a GP who treats the fee waiver as a mechanical conversion device: a way to take an effectively guaranteed return and reclassify it as capital gains. If the fund's portfolio has already appreciated substantially, if the profits interest is capped at a level the fund will almost certainly reach, or if the documentation is informal and not provided to LPs in advance, the IRS has a strong basis to recharacterize the arrangement. The GP's tax problem becomes the fund's legal exposure, and indirectly your problem as an LP holding a stake in an audited fund.

I pay particular attention to this issue in mid-market and smaller funds, where documentation practices are less uniform than at large institutional managers. A GP running a $150M fund with a $3M annual fee waiver, where the resulting profits interest draws from "net profits of specific identified transactions" rather than total fund performance, is triggering the fourth presumption in the proposed regulations. Ask the question. Get the documentation in writing. If the GP cannot explain the structure clearly and point to specific written notices sent to LPs before each fee period, treat that inability as informative in itself.

Frequently Asked Questions

Are management fee waivers legal in private equity funds?

Yes, management fee waivers are legal and widely used in the industry. The legal question is not whether they are permitted but whether a specific waiver qualifies as a legitimate profits interest under IRS Revenue Procedure 93-27, or whether it will be recharacterized as a disguised fee for services under Section 707(a)(2)(A). A waiver that carries genuine entrepreneurial risk, is documented in advance, and is disclosed to partners generally survives scrutiny. One that effectively guarantees the GP a return regardless of fund performance does not, according to the framework set out in Treasury's 2015 proposed regulations.

Were the IRS proposed regulations on management fee waivers ever finalized?

No. As of September 2026, Treasury has not finalized REG-115452-14, the proposed regulations published July 23, 2015 addressing disguised payments for services under Section 707(a)(2)(A). The Tax Law Center at NYU School of Law recommended in 2025 that Treasury finalize or republish these rules to stop improper use of fee waiver arrangements. In the interim, the IRS's stated position is that the proposed rules reflect current law, meaning the agency can challenge improperly structured waivers without waiting for finalization of the regulations.

Does a management fee waiver change what I pay as an LP?

Not directly. The fund still accrues the management fee expense, but instead of paying it out in cash, the GP receives a profits interest of equivalent economic value. Your share of fund expenses does not change as a direct result of the waiver. What changes is how the GP receives its compensation. A properly structured waiver delivers a capital-gains-eligible profits interest rather than cash ordinary income, and it ties the GP's total economics more closely to actual fund performance over the fund's life.

What is "bad dilution" and how does it relate to management fee waivers?

The ILPA Model Limited Partnership Agreement uses "bad dilution" to describe arrangements where GP principals receive management fee waivers that convert fee income into LP interests, directly reducing LP economics. In a properly structured fee waiver, the GP's profits interest comes from future fund gains and does not carve into LP distributions. In a bad-dilution scenario, the mechanics may reduce the effective return available to LPs by inflating GP profit participations beyond the agreed carried interest. The ILPA Model LPA recommends prohibiting bad dilution, and checking whether your fund's LPA follows this standard is a routine step in thorough LP due diligence.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.